Atlas FDA

VITEK 2 GRAM NEGATIVE AST FOR AMOXICILLIN/CLAVULANIC ACID

FDA premarket approval N50510/S124 · decided 2000-03-20

Approval details

PMA number
N50510
Supplement
S124
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VITEK 2 GRAM NEGATIVE AST FOR AMOXICILLIN/CLAVULANIC ACID
Generic name
Susceptibility test cards, antimicrobial
Applicant
Biomerieux Vitek, Inc.
Date received
1999-10-14
Decision date
2000-03-20
Days to decision
158 days
Decision code
APPR
Product code
LTW
Advisory committee
Microbiology
Expedited review
No
Location
Hazelwood, MO
Statement
Approval for the addition of the antibiotic amoxicillin/clavulanic acid at concentrations of 4/2, 16/8, and 32/16ug/ml to the Vitek 2 Gram Negative Susceptibility Test System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VIDAS D-DIMER (DD) ASSAY (K973819)Biomerieux Vitek, Inc.1998-03-10
VIDAS ROTAVIRUS (RTV) ASSAY (K972895)Biomerieux Vitek, Inc.1997-10-03
VIDAS ROTAVIRUS ASSAY (K965092)Biomerieux Vitek, Inc.1997-05-05
VIDAS C. DIFFICILE TOXIN A II ASSAY (K964887)Biomerieux Vitek, Inc.1997-04-08
VIDAS CHLAMYDIA BLOCKING ASSAY (K955627)Biomerieux Vitek, Inc.1996-10-07
VIDAS CREATINE KINASE MB ASSAY 30-421 (K962549)Biomerieux Vitek, Inc.1996-08-30
GRAM NEGATIVE IDENTIFICATION PLUS CARD (K962609)Biomerieux Vitek, Inc.1996-08-30
VITEK GRAM POSITIVE IDENTIFICATION CARD (GPI) (K952095)Biomerieux Vitek, Inc.1996-03-12